Unlike IMMP2L, mGPDH is highly tissue specific and its impairment would not affect all tissues, which means that mitochondrial glycerol-3-phosphate dehydrogenase represents a suitable target for cancer therapy. The gene discussed is GPD2; the disease is cancer.